alexa Selective Scatter Photocoagulation (SSP) in Patients with Proliferative Diabetic Retinopathy

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Selective Scatter Photocoagulation (SSP) in Patients with Proliferative Diabetic Retinopathy

The most significant complication of diabetes mellitus and which develops in 85% of all diabetics eventually is retinopathy. Diabetic retinopathy is the cause of blindness in approximately 2.5 million of the estimated 50 million blind people in the World. The number of patients with diabetes mellitus in the year 2013 was 382 million and is projected to rise to 592 million by 2035 (an increase by 55%).The estimated prevalence of diabetic retinopathy ranges from 2.0% to 11.7% in studied populations across the world.

Citation: Venkatesh P (2014) Selective Scatter Photocoagulation (SSP) in Patients with Proliferative Diabetic Retinopathy without High Risk Characteristics. J Laser Opt Photonics 1:101.